| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/27/2011 | US20110020232 Cancer treatment with gama-secretase inhibitors |
| 01/27/2011 | US20110020226 Particle structures comprising sterols and saponins |
| 01/27/2011 | US20110020222 Modified antibodies and methods of use |
| 01/27/2011 | US20110020221 Cancer stem cell expression patterns and compounds to target cancer stem cells |
| 01/27/2011 | US20110020220 Humanized antibodies against the beta-amyloid peptide |
| 01/27/2011 | US20110020219 Anti-human tenascin monoclonal antibody |
| 01/27/2011 | US20110020218 Novel anti cxcr4 antibodies and their use for the treatment of cancer |
| 01/27/2011 | US20110020216 Scaffolds for cell collection or elimination |
| 01/27/2011 | DE102009034553A1 Impfstoff zur Prävention von akuter lymphoblastischer Leukämie bei Kindern Vaccine for the prevention of acute lymphoblastic leukemia in children |
| 01/27/2011 | DE102009034150A1 Adsorbens zur Adsorption von Hepcidin Adsorbent for the adsorption of hepcidin |
| 01/27/2011 | CA2768562A1 Enzymatic composition for the digestion of chicken embryos |
| 01/27/2011 | CA2768494A1 Methods of treating her2 positive cancer with her2 receptor antagonist in combination with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 01/27/2011 | CA2768398A1 Dendritic cell vaccines for asparaginyl-.beta.-hydroxylase expressing tumors |
| 01/27/2011 | CA2767409A1 Methods and compositions for treating and preventing disease associated with .alpha.v.beta.5 integrin |
| 01/27/2011 | CA2767187A1 Vaccine |
| 01/26/2011 | EP2278028A1 Method for diagnosing non-small cell lung cancers |
| 01/26/2011 | EP2278024A1 Epitope cluster from NY-ESO-1 for the induction of anti-tumor immunogenicity |
| 01/26/2011 | EP2278023A1 Epitope cluster from Melan-A/MART-1 for the induction of anti-tumor immunogenicity |
| 01/26/2011 | EP2278013A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2278012A2 Avirulent, immunogenic flavivirus chimeras |
| 01/26/2011 | EP2278011A2 Neisseria meningitidis antigens |
| 01/26/2011 | EP2278010A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278009A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278008A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278007A1 Conserved neisserial antigens |
| 01/26/2011 | EP2278006A2 Neisserial antigens |
| 01/26/2011 | EP2278003A2 Method for controlling the activity of immunologically functional molecule |
| 01/26/2011 | EP2277920A2 Inhibitors of complement activation |
| 01/26/2011 | EP2277919A1 Treatment with anti-ERBB2 antibodies |
| 01/26/2011 | EP2277918A2 Mhc class I and II peptide antigens derived from tumour antigen 5t4 |
| 01/26/2011 | EP2277917A2 B7-H3L cell surface target and a family of antibodies recognizing that target |
| 01/26/2011 | EP2277916A2 Use of antibody to M-CSF |
| 01/26/2011 | EP2277914A2 Antigen binding domains from fish |
| 01/26/2011 | EP2277913A2 Antigen binding domains from fish |
| 01/26/2011 | EP2277910A1 Albumin fusion proteins |
| 01/26/2011 | EP2277908A2 IL-17A/F heterologous polypeptides, antibodies and therapeutic uses thereof |
| 01/26/2011 | EP2277907A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277906A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277905A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277904A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277903A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277902A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277901A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277897A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2277896A1 Nucleic acids and proteins from streptococcus groups A & B |
| 01/26/2011 | EP2277895A1 Nucleic acids and proteins from streptococcus groups A & B |
| 01/26/2011 | EP2277894A1 Nucleic acids and proteins from streptococcus groups A & B |
| 01/26/2011 | EP2277893A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/26/2011 | EP2277892A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/26/2011 | EP2277891A1 CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS POLYMERASE PAc-PB1n COMPLEX AND USES THEREOF |
| 01/26/2011 | EP2277889A2 Fusion proteins of albumin and interferon beta |
| 01/26/2011 | EP2277888A2 Fusion proteins of albumin and erythropoietin |
| 01/26/2011 | EP2277552A1 Mnk kinase proteins and diabetes |
| 01/26/2011 | EP2277543A1 Therapeutic anti-IL-1R1 monoclonal antibody |
| 01/26/2011 | EP2277542A1 Modified antibodies to prostrate-specific membrane antigen and uses thereof |
| 01/26/2011 | EP2277541A1 Multivalent vaccine composition |
| 01/26/2011 | EP2277540A2 Polyanionic polymer adjuvants for haemophilus influenza B saccharide vaccines |
| 01/26/2011 | EP2277539A2 Neisseria meningitidis conjugate combination vaccine |
| 01/26/2011 | EP2277538A1 Combined meningitis vaccines |
| 01/26/2011 | EP2277537A2 Neisseria meningitidis conjugate combination vaccine |
| 01/26/2011 | EP2277536A2 Purification of bacterial capsular polysaccharides |
| 01/26/2011 | EP2277535A2 Vaccine |
| 01/26/2011 | EP2277534A1 Immunogenic and therapeutic compositions for streptococcus suis |
| 01/26/2011 | EP2277533A2 Methods for vaccinating against malaria |
| 01/26/2011 | EP2277532A1 Novel composition and methods for the treatment of immune related diseases |
| 01/26/2011 | EP2277531A1 Treatment of cns damage |
| 01/26/2011 | EP2277506A1 Non-polar buccal spray of a sedative |
| 01/26/2011 | EP2277049A2 Autoantibodies in the detection and treatment of cancer |
| 01/26/2011 | EP2276509A2 Detection and tratment of pancreatic, ovarian and other cancers |
| 01/26/2011 | EP2276508A1 Delivery of lfa-1 antagonists to the gastrointestinal system |
| 01/26/2011 | EP2276507A1 CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF |
| 01/26/2011 | EP2276501A2 Methods and compositions for genetic and retinal disease |
| 01/26/2011 | EP2129684B1 Method of purification of hydrophobic proteins |
| 01/26/2011 | EP1912665B1 Vaccine against feline calicivirus (fcv) comprising a fcv capsid protein or an isolated fcv capsid protein comprising protein sequence seq id no: 13 or protein sequences having at least 95% identity thereto. |
| 01/26/2011 | EP1725261B1 Use of agonists and antagonists of interleukin-33 (il-33) |
| 01/26/2011 | EP1660513B1 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 01/26/2011 | EP1603511B1 Treatment of igai deposition diseases |
| 01/26/2011 | EP1404365B1 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 01/26/2011 | EP1289545B1 Synthetic vaccine for tick control |
| 01/26/2011 | EP0951552B1 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 01/26/2011 | EP0948625B1 Uspa1 and uspa2 antigens of moraxella catarrhalis |
| 01/26/2011 | EP0946725B1 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| 01/26/2011 | EP0833662B2 A vaccine composition comprsing a Haemophilus influenzae B polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 01/26/2011 | CN101959529A Methods of treating inflammatory pain |
| 01/26/2011 | CN101959528A Methods of treating chronic pain |
| 01/26/2011 | CN101959527A Process for stabilizing an adjuvant containing vaccine composition |
| 01/26/2011 | CN101959526A Use of interleukin-1 conjugates in the treatment of diabetes |
| 01/26/2011 | CN101959420A Immunogenic compositions |
| 01/26/2011 | CN101957379A HPPCn antibody, antisense oligonucleotide and application of RNA interference in tumor diagnosis and treatment |
| 01/26/2011 | CN101955997A Compositions and method for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 01/26/2011 | CN101955956A Eimeria tenella calcium-dependent protein kinase gene and application thereof |
| 01/26/2011 | CN101955941A Porcine interferon gene family and application thereof in blue-ear porcine disease resistant medicament and vaccine adjuvant |
| 01/26/2011 | CN101955917A Virus-like particle containing porcine parvovirus VP2 and somatostatin chimeric protein |
| 01/26/2011 | CN101955915A Method for producing influenza virus vaccine |
| 01/26/2011 | CN101955905A Bacterial strain for producing Escherichia coli K88ac-K99-ST1-LTB quadrivalent gene engineering inactivated vaccines and inactivated vaccine production method |
| 01/26/2011 | CN101955545A Multi-target recombination gene and application of protein thereof in preventing and treating infection of helicobacter pylori |
| 01/26/2011 | CN101955544A Candida albicans secreted aspartic proteinase (Sap2) coding epitope sequence-synthesizing and bacteriophage shell protein-bonding hybrid protein and use thereof |
| 01/26/2011 | CN101954092A Genetic engineering vaccine of lymphocystis disease of flounder paralichthys olivaceus and production method thereof |
| 01/26/2011 | CN101954080A Compound-molecule adjuvant for swine foot-and-mouth vaccine and preparation method thereof |
| 01/26/2011 | CN101954079A Vaccine adjuvant of swine mycoplasmal pneumonia live vaccine, and preparation method and application thereof |